First-Time Generalized Seizure and Headache – Case Report
Neurovaskuläres Zentrum shared a post on LinkedIn:
“-A 52-year-old male patient presented due to a first-time generalized seizure and headache
-CCT revealed strong suspicion of thrombosis of a prominent cortical vein in the left frontotemporal region, particularly involving the Vein of Trolard and the Vein of Sylvius and their branches, indicated by pre-existing hyperdensity
-CTA showed an isolated occlusion of the left superficial superior anastomotic vein (Vein of Trolard), extending into the superficial middle cerebral vein (Vein of Sylvius) and into the sphenoparietal sinus
-The patient was admitted to the stroke unit and therapeutic anticoagulation was initiated using an aPTT-guided heparin infusion
-Over the course of hospitalization, there was clinical deterioration and worsening of headaches
-Imaging showed slight progression of the thrombosis
-Follow-up cMRI showed a localized diffusion restriction surrounding the thrombosis, indicating the onset of thrombus resorption. FLAIR sequences showed faint parieto-temporal and occipito-temporal hyperintensities, consistent with mild edema
-Overlapping anticoagulation therapy with warfarin (Marcoumar) was initiated
-At last follow-up, the patient still had mild aphasia with somewhat hesitant speech and fine motor impairment of the right hand.
Prof. Dr. Wilhelm Nacimiento Dr. med. Martin Schlunz-Hendann Prof. Dr. Martin Scholz”
Stay updated with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals